The expression of E-cadherin frequently diminishes as the tumor progresses, and abnormalities of E-cadherin expression have been associated with decreased apoptosis in GBC [88] and genomic instability during the process of neoplastic transformation [90]. Here, CDH1 is linked to neoplasm.